Who holds the position of Representative Director and President at GENOVA Inc., and in which district of Tokyo is the company's head office located?

Tomoki Hirase serves as the Representative Director and President of GENOVA Inc., whose head office is situated in Shibuya‑ku, Tokyo.

Did the absorption‑type merger of GENOVA DESiGN Inc. involve issuing new shares or paying merger consideration, and will there be any changes to GENOVA Inc.'s trade name, location, representative, business activities, capital, or fiscal year?

The merger did not involve issuing new shares or paying any merger consideration, and GENOVA Inc. confirmed that there will be no changes to its trade name, location, representative, business activities, capital, or fiscal year.

According to the timely disclosure dated February 13, 2026, what impact is expected on GENOVA Inc.'s consolidated business performance as a result of the merger with its wholly‑owned subsidiary?

GENOVA Inc. stated that because the merger is between the company and its wholly‑owned subsidiary, there will be no impact on its consolidated business performance.

AI News NQ Analysis

Announcement Regarding the Completion of Absorption-type Merger of Wholly-Owned Subsidiary (GENOVA DESiGN Inc.)

NQ Score 100/100

AI Summary (NQ-processed)

GENOVA Inc. has completed the absorption-type merger of its wholly-owned subsidiary, GENOVA DESiGN Inc. (GD Inc.), effective April 1, 2026. This merger aims to strengthen collaboration between GENOVA's medical platform business and its production department, accelerate decision-making, improve service quality, and enhance corporate value through reduced administrative costs. The merger, being with a 100% owned subsidiary, will not impact consolidated business performance.

AI analysis data is not yet available.

Frequently Asked Questions

Q: When did GENOVA Inc. announce that the absorption‑type merger of its wholly‑owned subsidiary GENOVA DESiGN Inc. was completed, and what was the effective date of the merger?: A: GENOVA Inc. announced the merger was completed on April 1, 2026, and the effective date of the absorption‑type merger was also April 1, 2026.
Q: Who holds the position of Representative Director and President at GENOVA Inc., and in which district of Tokyo is the company's head office located?: A: Tomoki Hirase serves as the Representative Director and President of GENOVA Inc., whose head office is situated in Shibuya‑ku, Tokyo.
Q: What are the primary objectives of merging GENOVA DESiGN Inc. into GENOVA Inc., especially concerning the collaboration between the medical platform business and the production department?: A: The merger aims to strengthen collaboration between GENOVA Inc.'s medical platform business and its production department, accelerate decision‑making, improve service quality, reduce administrative costs, and enhance overall corporate value.
Q: Did the absorption‑type merger of GENOVA DESiGN Inc. involve issuing new shares or paying merger consideration, and will there be any changes to GENOVA Inc.'s trade name, location, representative, business activities, capital, or fiscal year?: A: The merger did not involve issuing new shares or paying any merger consideration, and GENOVA Inc. confirmed that there will be no changes to its trade name, location, representative, business activities, capital, or fiscal year.
Q: According to the timely disclosure dated February 13, 2026, what impact is expected on GENOVA Inc.'s consolidated business performance as a result of the merger with its wholly‑owned subsidiary?: A: GENOVA Inc. stated that because the merger is between the company and its wholly‑owned subsidiary, there will be no impact on its consolidated business performance.